Profound Medical (PROF)

• Market cap: $268M
• 1 day: 1.79%
• 5 days: 3.36%
• 1 month: 10.98%
• 3 months: 10.15%
• 6 months: -4.9%
• Year to date: -3.66%
• 1 year: 32.97%
• 5 years: -46.52%
• 10 years: -25.3%
• Sector: Healthcare
• Industry: Medical Devices

About: Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Employees: 162